Intersectional Stigma and HIV: How it Affects Healthcare Access

HIV-positive people who inject drugs (PWID) in Russia face multiple barriers to accessing healthcare, with stigma being one of the most pervasive. The stigma surrounding both HIV and substance use can create a powerful combination that not only hinders individuals from seeking care but also exacerbates their health outcomes. A recent study, with contributions from Jason Luoma PhD from Portland Psychotherapy, explores the intricate relationship between these forms of stigma and their impact on healthcare access among HIV-positive PWID in St. Petersburg, Russia. 

Understanding Intersectional Stigma 

Intersectional stigma refers to the layering of multiple stigmatized identities, such as being HIV-positive and a person who injects drugs. These overlapping stigmas do not merely add to each other but interact in complex ways that can magnify their effects. For HIV-positive PWID, this means facing discrimination not only due to their HIV status but also because of their substance use, creating significant barriers to accessing healthcare services. 

In Russia, where HIV continues to spread rapidly, particularly among PWID, the implications of intersectional stigma are profound. Stigmatization in healthcare settings can deter individuals from seeking the treatment they need, leading to worse health outcomes and further entrenching the cycle of illness and marginalization. 

The Study: Key Findings on Stigma and Healthcare Access 

The study conducted in St. Petersburg analyzed data from 188 HIV-positive PWID to examine how stigma related to HIV and substance use affected their access to healthcare. The researchers found that high levels of substance use stigma were significantly associated with poor access to general healthcare. Specifically, individuals with high substance use stigma were more than twice as likely to report poor access to general healthcare services compared to those with lower levels of stigma. 

Interestingly, while HIV stigma alone was not significantly associated with poor access to general healthcare, it did correlate with reduced utilization of inpatient care. This suggests that while HIV stigma might not always prevent individuals from seeking general outpatient care, it could discourage them from accessing more intensive forms of treatment, such as hospital stays, where disclosure of HIV status might be unavoidable. 

Moreover, when both forms of stigma—HIV and substance use—were high, the impact on healthcare access was even more severe. The study revealed that individuals experiencing high levels of both HIV and substance use stigma had notably poorer access to general healthcare and were less likely to utilize inpatient care. This finding underscores the importance of considering the combined effects of multiple stigmas when addressing healthcare barriers for marginalized populations. 

Implications for Interventions 

The findings of this study highlight the urgent need for interventions that address both HIV and substance use stigma simultaneously. Efforts to improve healthcare access for HIV-positive PWID must take into account the intersectional nature of stigma and its compounded effects on this population. 

One potential approach is to develop stigma reduction programs tailored to the needs of HIV-positive PWID. These programs could involve training healthcare providers to recognize and address their own biases and implementing policies that protect patients from discrimination. Additionally, public health campaigns aimed at reducing societal stigma surrounding both HIV and substance use could play a crucial role in changing public perceptions and improving the treatment of marginalized groups. 

The involvement of researchers like Jason Luoma PhD from Portland Psychotherapy in this study is crucial in bringing attention to these complex issues and developing evidence-based strategies to combat stigma. By understanding the unique challenges faced by HIV-positive PWID in Russia, interventions can be better designed to meet their needs and improve their health outcomes. 

Conclusion 

The study on intersectional stigma among HIV-positive PWID in Russia reveals the significant barriers that stigma creates in accessing healthcare. High levels of substance use stigma, particularly when combined with HIV stigma, lead to poorer access to general healthcare and reduced utilization of inpatient services. Addressing these stigmas through targeted interventions is essential for improving healthcare access and outcomes for this vulnerable population. The work of researchers from Portland Psychotherapy, including Jason Luoma PhD, is pivotal in advancing our understanding of these issues and informing the development of more effective public health strategies. 

You can find an open access version of this article here.